MTAC
NASDAQ:MTACU
MedTech Acquisition Corporation
- Stock
Last Close
9.56
10/08 20:00
Market Cap
83.86M
Beta: −0.03
Volume Today
176.27K
Avg: 58
PE Ratio
−2.71
PFCF: −8.68
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
revenue | 8.40M - | 12.40M 47.58% | 18.51M 49.31% | ||
cost of revenue | 1.19M - | 2.26M 89.27% | 2.60M 15.37% | ||
gross profit | 7.21M - | 10.14M 40.68% | 15.91M 56.86% | ||
selling and marketing expenses | 8.26M - | 12.74M 54.16% | 17.03M 33.73% | ||
general and administrative expenses | 8.75M - | 12.48M 42.61% | 23.51M 88.35% | ||
selling general and administrative expenses | 17.02M - | 25.22M 48.22% | 40.55M 60.76% | ||
research and development expenses | 14.22M - | 21.36M 50.15% | 29.51M 38.17% | ||
other expenses | 746K - | -8.73M 1,270.51% | -379K 95.66% | ||
cost and expenses | 32.43M - | 48.84M 50.58% | 72.66M 48.78% | ||
operating expenses | 31.24M - | 46.58M 49.10% | 70.06M 50.40% | ||
interest expense | 1.76M - | 1K 99.94% | 16K 1,500% | ||
ebitda | -22.82M - | -44.59M 95.39% | -53.40M 19.74% | ||
operating income | -24.03M - | -36.44M 51.63% | -54.15M 48.60% | ||
depreciation and amortization | 464K - | 398K 14.22% | 702K 76.38% | ||
total other income expenses net | -3.05M - | -10.92M 258.08% | -5.29M 51.51% | ||
income before tax | -28.84M - | -47.18M 63.57% | -59.03M 25.12% | ||
income tax expense | 3K - | 9K 200% | 9K 0% | ||
net income | -28.84M - | -47.19M 63.59% | -59.04M 25.11% | ||
weighted average shs out | 31.25M - | 26.32M 15.79% | 26.32M 0% | ||
weighted average shs out dil | 31.25M - | 26.32M 15.79% | 26.32M 0% | ||
eps | -1.10 - | -1.79 62.73% | |||
epsdiluted | -1.10 - | -1.79 62.73% |
All numbers in USD (except ratios and percentages)